Wall Street analysts expect MAXIMUS, Inc. (NYSE:MMS) to report $608.10 million in sales for the current quarter, according to Zacks. Two analysts have issued estimates for MAXIMUS’s earnings. The highest sales estimate is $625.39 million and the lowest is $590.80 million. MAXIMUS reported sales of $623.15 million in the same quarter last year, which indicates a negative year over year growth rate of 2.4%. The business is scheduled to issue its next quarterly earnings report on Thursday, February 14th.
According to Zacks, analysts expect that MAXIMUS will report full year sales of $0.00 for the current fiscal year. For the next fiscal year, analysts forecast that the firm will report sales of $2.59 billion, with estimates ranging from $2.52 billion to $2.67 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for MAXIMUS.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Tuesday, November 20th. The health services provider reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). The company had revenue of $558.50 million for the quarter, compared to the consensus estimate of $587.58 million. MAXIMUS had a return on equity of 20.23% and a net margin of 9.23%. The business’s revenue for the quarter was down 10.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.81 earnings per share.
In other news, General Counsel David Francis sold 6,220 shares of the company’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $63.86, for a total value of $397,209.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Vice Chairman Richard A. Montoni sold 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 18th. The shares were sold at an average price of $65.81, for a total value of $987,150.00. Following the completion of the transaction, the insider now directly owns 493,476 shares of the company’s stock, valued at $32,475,655.56. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 66,222 shares of company stock valued at $4,307,909. 3.10% of the stock is currently owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the company. Bruderman Asset Management LLC bought a new position in shares of MAXIMUS in the second quarter valued at approximately $119,000. Fort L.P. purchased a new position in MAXIMUS in the second quarter valued at approximately $120,000. Violich Capital Management Inc. purchased a new position in MAXIMUS in the second quarter valued at approximately $204,000. Advisors Asset Management Inc. lifted its stake in MAXIMUS by 132.3% in the second quarter. Advisors Asset Management Inc. now owns 3,807 shares of the health services provider’s stock valued at $461,000 after purchasing an additional 2,168 shares during the last quarter. Finally, Engineers Gate Manager LP purchased a new position in MAXIMUS in the third quarter valued at approximately $254,000. 93.53% of the stock is owned by institutional investors.
MMS traded up $0.89 during midday trading on Friday, reaching $67.43. 249,564 shares of the company were exchanged, compared to its average volume of 394,387. The firm has a market capitalization of $4.27 billion, a P/E ratio of 19.83, a P/E/G ratio of 2.34 and a beta of 0.97. MAXIMUS has a one year low of $60.00 and a one year high of $72.71.
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 30th. Stockholders of record on Thursday, November 15th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, November 14th. This is a positive change from MAXIMUS’s previous quarterly dividend of $0.05. This represents a $1.00 annualized dividend and a dividend yield of 1.48%. MAXIMUS’s dividend payout ratio is currently 29.41%.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
See Also: What is a Reverse Stock Split?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.